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STUDY PROTOCOL Open Access
Understanding multifactorial influences on the
continuum of maternal weight trajectories in
pregnancy and early postpartum: study protocol,
and participant baseline characteristics
Tiffany A Moore Simas1*, Silvia Corvera2, Mary M Lee3, NingNing Zhang3, Katherine Leung1, Barbara Olendzki4,
Bruce Barton5 and Milagros C Rosal4
Abstract
Background: Maternal and offspring immediate and long-term health are affected by pregnancy weight gain and
maternal weight. This study was designed to determine feasibility of: 1) recruiting a socio-economically and
racially/ethnically diverse sample of pregnant women into a longitudinal observational study, including consenting
the women for serial biologic specimen evaluations; 2) implementing comprehensive assessments (including
biologic, anthropometric, behavioral, cognitive/psychosocial and socio-demographic, and cultural measures) at
multiple time points over the study period, including collecting biologic specimens at planned and unplanned
pregnancy delivery times; and 3) retaining the sample for one year into the postpartum period. Additionally, the
study will provide preliminary data of associations among hypothesized predictors, mediators and moderators of
pregnancy and post-partum maternal and infant weight trajectories. The study was conceptualized under a
Biopsychosocial Model using a lifespan approach. Study protocol and baseline characteristics are described.
Methods/Design: We sought to recruit a sample of 100 healthy women age 18–45 years, between 28–34 weeks
gestation, with singleton pregnancies, enrolled in care prior to 17 weeks gestation. Women provide written
consent for face-to-face (medical history, anthropometrics, biologic specimens), and paper-and-pencil assessments,
at five time points: baseline (third trimester), delivery-associated, and 6-weeks, 3-months and 6-months postpartum.
Additional telephone-based assessments (diet, physical activity and breastfeeding) administered baseline and
three-months postpartum. Infant weights are collected until 1-year of life. We seek to retain 80% of participants at
six-months postpartum and 80% of offspring at 12-months.
110 women were recruited. Sample characteristics include: mean age 28.3 years, BMI 25.7 kg/m2, and gestational age at
baseline visit of 32.5 weeks. One-third of cohort was non-white, over a quarter were Latina, and almost a quarter were
non-US born. The cohort majority was multigravida, had graduated high school and/or had higher levels of education,
and worked outside the home.
Discussion: Documentation of study feasibility and preliminary data for theory-driven hypothesis of maternal and child
factors associated with weight trajectories will support future large scale longitudinal studies of risk and protective
factors for maternal and child health. This research will also inform intervention targets facilitating healthy maternal
and child weight.
Keywords: Design, Methods, Biopsychosocial, Pregnancy, Postpartum, Weight gain, Weight loss, Weight retention,
Maternal and child health, Well being
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Background
Maternal weight before, during, and after pregnancy
is of considerable public health importance given its
impact on both immediate and long-term maternal and
child health. The majority of women and thus their
children are at weight-related health risk when consider-
ing: (1) two-thirds of American women are overweight or
obese [1-4], with nearly 50% entering pregnancy over-
weight or obese, and one in five obese [5], (2) up to 84%
of overweight and 74% of obese pregnant women gain
above recommended guidelines [6], (3) up to two thirds of
women retain weight after pregnancy [7], and (4) some
women continue to gain weight rather than lose weight in
the postpartum period [8]. Excessive gestational weight
gain contributes to subsequent postpartum weight reten-
tion [7], and failure to lose pregnancy weight by six
months postpartum predicts long-term obesity [9,10] with
women retaining an average of 3 kg per pregnancy at
10 years [11]. Given well-established associations between
obesity and an array of chronic maternal health condi-
tions, including cardiometabolic diseases [12-15] and
some cancers [16], achieving a healthy weight gain during
pregnancy, and preventing postpartum weight retention,
are critical to the long-term health of many women [9,10].
Maternal obesity is associated with increased risks of
gestational diabetes, large for gestational age neonates,
and childhood obesity [17]. Excessive maternal weight
gain in pregnancy is also associated with childhood
obesity [18] which is subsequently associated with long-
term offspring consequences including cardiometabolic
and neuro-developmental disorders. The growing body
of evidence in support of the Developmental Origins of
Health and Disease Hypothesis (DOHaD, the Barker hy-
pothesis) [19] suggests that optimizing maternal health
before and during pregnancy is critical for improved out-
comes not just for women but also for their children.
Acting upon scientific literature on weight gain pat-
terns before, during, and after pregnancy, and in the
context of a life-stage framework [3], the Institute of
Medicine (IOM) issued gestational weight gain recom-
mendations in 1999, with revisions in 2009. Current rec-
ommendations encourage appropriate gain for women
with underweight BMIs (<18.5 kg/m2) of 28–40 pounds,
normal BMIs (18.5-24.9 kg/m2) of 25–35 pounds, over-
weight BMIs (25.0-29.9 kg/m2) of 15–25 pounds, and
obese BMIs (≥30 kg/m2) of 11–20 pounds [3]. The 2009
IOM report also identified a set of consequences that
were potentially causally related to gestational weight
gain with postpartum weight retention and cesarean de-
livery emerging as being most important for maternal
health; and small for gestational age neonates, large for
gestational age neonates, preterm birth and childhood
obesity emerging as the most important consequences
for infant health [3].
In an effort to promote these guidelines, several
randomized control trials have tested interventions
to optimize gestational weight gain; however, such inter-
ventions have had limited effectiveness [20-26]. Similarly,
randomized intervention trials for post-partum weight
loss have been limited in their effectiveness [24,27]. Stud-
ies have predominantly intervened on diet and exercise,
and evaluated effects of breastfeeding [28-31]. With few
exceptions [32], the interventions have lacked theoretical
grounding and have been limited in the potential array of
variables investigated.
The general non-pregnant obesity and weight gain lit-
erature has broad comprehensive models for under-
standing weight and obesity. For example, there has
been increased attention to the roles and interplay of re-
duced sleep [33-35], increased stress [36-38] and depres-
sion, all factors that fluctuate during pregnancy and the
post-partum period [39-42]. However, examination of
these factors has received limited research attention with
regards to pregnancy and post-partum weight. In
addition to psychosocial factors, biologic considerations
include differences in the deposition and mobilization of
peripheral and central subcutaneous adipose tissue in
the non-pregnant, pregnant and lactating states [43-46].
Given inadequate literature in these and relevant areas,
action items in the 2009 IOM report included a recom-
mendation to conduct comprehensive studies that examine
how dietary intake, physical activity, dieting practices, food
insecurity and, more broadly, the social, cultural and envir-
onmental context affect gestational weight gain [3] in large
and diverse populations of women. Gestational weight gain
and postpartum weight are part of a continuum that needs
to be considered in identifying risk factors and mecha-
nisms of postpartum weight retention. Such knowledge
is critical to the design of future interventions that have
the potential to substantially improve maternal and conse-
quently, child health.
A lifespan approach to the Biopsychosocial Model [47]
provides a comprehensive template for examining how the
complex interactions among an individual’s biological,
psychological and contextual factors affect weight and
health outcomes during the childbearing years and be-
yond, for both the mother and the child. In the current
study we conceptualize women’s weight trajectory during
both the pregnancy and postpartum periods in addition to
long-term maternal and child health and well-being within
this biopsychosocial framework (Figure 1). Our study was
designed to understand multifactorial influences on mater-
nal weight trajectories that begin in pregnancy and extend
into the postpartum period.
Study aims
To establish the feasibility of: 1) recruiting a socio-
economically and racially/ethnically diverse sample of
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pregnant women into a longitudinal observational study,
including consenting the women for serial biologic speci-
men evaluations; 2) implementing comprehensive assess-
ments (including biologic, anthropometric, behavioral,
cognitive/psychosocial and socio-demographic and cul-
tural measures) at multiple time points over the study
period, including collecting biologic specimens at planned
and unplanned pregnancy delivery times; and 3) retaining
the sample for one year into the postpartum period.
Additionally, the study will provide preliminary data of
associations among hypothesized predictors, mediators
and moderators of pregnancy weight gain and postpartum
weight loss and retention, in accordance with the multifac-
torial model shown in Figure 1. Ultimately, this research
will inform a future larger study of risks and protective
factors for gestational weight gain and post-partum weight
loss, with effective interventions to optimize both. This
paper describes the study design, assessment protocols,
and baseline demographic characteristics of 110 diverse
pregnant women and their babies.
Methods
Study design & overview
The Pregnancy and Postpartum Observational Determi-
nants Study (PPODS) is a prospective cohort feasibility
study approved by the University of Massachusetts Medical
School Institutional Review Board human subjects commit-
tee. In accordance with the Lifespan Biopsychosocial Model
used as the framework for this study, comprehensive as-
sessments starting in pregnancy and continuing over the
postpartum period include demographic, biologic including
anthropometric, behavioral, cognitive/psychological and
socio-cultural factors hypothesized to influence gestational
weight gain (GWG), postpartum weight loss, and clinical
outcomes of healthy women and their offspring. At present,
study recruitment is complete and participant follow up
and analyses are ongoing.
Study setting and population
The study is being conducted at the ambulatory faculty and
resident obstetrical practices at a large tertiary hospital in
Figure 1 Transtheoretical framework based on lifespan biopsychosocial model.
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Central Massachusetts, UMass Memorial Medical Center
(UMMMC), in Worcester, MA, where approximately 20
residents, 3 nurse practitioners, and 14 attending faculty
obstetricians provide prenatal and postpartum care to
ethnically and socioeconomically diverse women. These
practices deliver ~1,600 of the ~4, 000 pregnancies that are
admitted to UMMMC each year.
Eligibility criteria include: (1) age ≥18 or ≤ 45 years,
(2) singleton gestation, (3) English speaking, (4) no
history of pre-gestational or current gestational diabetes,
(5) no evidence of alcohol or substance abuse, (6) not tak-
ing medications that affect weight (anti-hypertensives, hy-
poglycemics, steroids, second generation anti-psychotics,
anti-epileptics and thyroid-related pharmaceuticals), (7)
no evidence of HIV, hepatitis, autoimmune disease, eating
disorder history, or bariatric surgery history, and (8) pre-
natal care initiated ≤ 16 weeks and 6 days gestational age.
Age of inclusion was restricted as GWG recommenda-
tions are somewhat controversial in adolescents and gen-
eral weight gain increases with advancing age. Multiple
gestations were excluded due to differences in GWG rec-
ommendations for twins, triplets and higher order multi-
ples. Non-English speaking subjects were excluded due to
limited resources. Subjects with diabetes were ineligible
due to high potentiality of receiving treatments that affect
weight (i.e., selected medications, dietary interventions).
Subjects with substance abuse history, with prescriptions
for aforementioned medication groups and with disease
states listed were excluded due to effects on weight, weight
gain and diet and on potential compliance and reliability
in the former population. Subjects had to have initiated
care in early pregnancy so that weight measurements
throughout pregnancy were available for analyses.
Participant screening and recruitment
Identification of eligible women occurred proactively.
Between 24–28 weeks gestation, obstetric providers at
study practices carry out universal gestational diabetes
screening in all gravidas without pre-gestational type 1
or type 2 diabetes mellitus with a 50 g glucose load
followed by plasma glucose determination in the subse-
quent hour [48]. For tracking purposes, a list of consecu-
tive patients undergoing gestational diabetes screening is
generated real-time; this prompted review of associated
laboratory results by a trained and supervised study co-
ordinator using a HIPAA waiver and the clinical care
team. The study coordinator then reviewed medical re-
cords of women without gestational diabetes for additional
study inclusion/exclusion criteria. Women meeting study
criteria who had an upcoming appointment at a gestational
age < 34 weeks were placed on a list of potentially eligible
women. Their health care providers were subsequently
contacted for permission to approach the women and then
a letter was mailed to inform potential participants about
the study and that they would be approached at their next
face-to-face prenatal visit. To support study recruitment ef-
forts, advertisements were placed in public waiting rooms
and examination rooms of the obstetric practices, and their
physicians were also encouraged to refer patients. All eli-
gible women who expressed interest then provided written
informed consent and were assigned a unique alpha-
numeric identifier.
Measurements and assessments
Women were assessed at baseline, at delivery, in the im-
mediate in-patient postpartum period and then postpar-
tum at 6 weeks, 3 months and 6 months. Assessments
included demographic, biologic including anthropometric,
behavioral, cognitive/psychological and sociocultural eval-
uations. See Table 1 for the assessment schedule. In recog-
nition of participants’ time commitments, women receive
gift card incentives following each assessment. Data collec-
tion time points for infants are birth, 3-months, 6 months
and at 1 year of age. Additionally, infant weight data are
obtained from their pediatricians until one year of life.
Demographic
Baseline demographic data are collected on the day of
enrollment by study personnel through personal inter-
view. Demographic factors of interest include age, race/
ethnicity, educational attainment, marital status, occupa-
tion, work status, insurance type, household size and in-
come and other housing-related factors. Demographics
with potential for change over time are queried at each
postpartum visit.
Biological (Including Medical History, Clinical Assessments,
Anthropometric Data and Genetics)
Baseline medical history is collected on the day of en-
rollment by study personnel through personal and med-
ical record review. Characteristics surveyed include age
at menarche, parity, interval from last pregnancy and
obstetric history including prior complications like ges-
tational diabetes, hypertensive disorders of pregnancy,
prolonged bedrest and others. Medical chart review is
performed to confirm or clarify aforementioned infor-
mation and to retrieve information on medication use,
pregnancy dating, and weight-related services such as
nutrition consultations. Estimated delivery date and thus
gestational age is determined by chart review, based on
1st trimester ultrasound or clinical dating that agrees
with 2nd trimester ultrasound [49].
Blood pressure is measured three times in the right
arm after 15 mins of sitting [50] and with a 15 minute
lapse between each measurement, using an automated
Dinamap XL blood pressure monitor [51]. Urine is evalu-
ated for the presence of protein or glucose using Siemens
multistix 10SG reagent strips for urinalysis.
Moore Simas et al. BMC Pregnancy and Childbirth  (2015) 15:71 Page 4 of 12
Table 1 Schedule of study assessments
Study assessments Study time points
Baseline* Delivery Postpartum
0-4d 6 wks 3 mos 6 mos 1 year
Review study protocol & informed consent ✓
Confirmation inclusion/exclusion criteria
Demographics ✓
Biological Medical History ✓
Blood Pressure ✓ ✓ ✓ ✓ ✓
Urine for protein and glucose ✓ ✓ ✓ ✓ ✓
Height ✓
Prepregnancy Weight & BMI ✓
Skin Fold Thickness (SFT) ✓ ✓ ✓ ✓ ✓
Waist, Hip and Arm Circumferences ✓ ✓ ✓ ✓ ✓
Genetics (Maternal buccal swab, umbilical
cord and blood, placenta, adipose tissue†)‡
✓
Behavioral 24 Hour Dietary and Physical Activity Recalls ✓ ✓
3-Factor Eating Questionnaire R18-modified ✓ ✓ ✓ ✓ ✓
Food Craving Inventory ✓ ✓ ✓ ✓ ✓
Pregnancy and Physical Activity Questionnaire
(PPAQ) (modified postpartum)
✓ ✓ ✓ ✓ ✓
Breastfeeding-Infant Feeding Surveys ✓ ✓ ✓ ✓ ✓
Pittsburgh Sleep Quality Index ✓ ✓ ✓ ✓
Cognitive/psychological Spielberger Trait Anxiety Inventory ✓ ✓ ✓ ✓ ✓
Perceived Stress Scale ✓ ✓ ✓ ✓ ✓
Quality of Life SF-12 with RAND score ✓ ✓ ✓ ✓ ✓
Happiness Scale ✓ ✓ ✓ ✓ ✓
Edinburgh Postnatal Depression Scale ✓ ✓ ✓ ✓ ✓
Pregnancy & Weight Gain Attitude
Scale (PWGAS), modified
✓
Socio-cultural Weight gain advice and purposeful
weight control attempts survey
✓ ✓ ✓ ✓
Social Support ✓ ✓ ✓ ✓ ✓
Life Events ✓ ✓ ✓ ✓ ✓
Biologic pathways
(specimens & imaging)‡
Maternal Blood ✓ ✓ ✓ ✓ ✓ ✓
Umbilical Cord Blood ✓
Placenta ✓
Umbilical Cord ✓
Adipose Tissue† (Subcutaneous & Omental) ✓
Magnetic Resonance Imaging† ✓
Mouthwash Buccal Epithelial Cells for DNA ✓ ✓
Weight outcomes Maternal Weight ✓ ✓ ✓ ✓ ✓ ✓
Neonatal Weight & Length ✓ ✓ ✓ ✓ ✓ ✓
*Baseline visit occurring in pregnancy at approximately 28–34 weeks gestation.
†Subset of subjects only.
‡Participation in biologic specimen component of study was optional.
Moore Simas et al. BMC Pregnancy and Childbirth  (2015) 15:71 Page 5 of 12
Height is measured using a 1 Seca 213 Portable Stadi-
ometer. Prepregnancy weight is self-reported at first
prenatal visit and abstracted from prenatal record. Pre-
pregnancy body mass index (BMI) calculated as prepreg-
nancy weight (kg)/height2 (meters2). BMI considered
continuously and categorically as per World Health
Organization criteria: underweight (<18.5 kg/m2), nor-
mal (18.5-24.9 kg/m2), overweight (25.0-29.9 kg/m2) and
obese (≥30 kg/m2) [3]. In accordance with prenatal care
standard, weight and gestational age at each visit is re-
corded from digital clinical scales and was abstracted
from records.
Skinfold thickness (SFT) measurements are performed
at seven body sites (biceps, triceps, subscapular, iliac,
costal, mid thigh, lower thigh), on the subjects’ right side
with a calibrated Harpenden skinfold caliper (British
Indicators, Sussex, UK), by methods and placements as
described by Huston-Presley et al. [52], to quantify tissue
distribution. All skinfolds are assessed three times at
each study time point; a mean value of the three is com-
puted. In cases where two measurements differ by more
than 1.0 mm, the skin fold is measured a fourth time
and the mean value of the four values is averaged.
Body circumferences (upper arm, waist and hip) are ob-
tained recognizing that waist measurements are limited
in pregnancy and the immediate postpartum period.
Two waist circumferences are measured: (1) midway be-
tween the lowest lateral border of the ribs and the top of
the iliac crest as per WHO recommendations and (2) at
the top of the iliac crest as per NIH standards, in relaxed
subjects during expiration [53]. Hip circumference is
measured at the maximum circumference overlying the
buttocks. Arm circumference measured midway between
the axilla and the elbow. All circumferences measured 3
times and an average calculated.
Biologic specimens are collected over the course of the
study with the goal of gaining insight into biologic path-
ways and epigenetic signatures affected by or contribut-
ing to weight outcomes. As the main aims of this study
did not focus specifically on biomarkers and biosignature
evaluation, but rather the acceptability of serial biospeci-
mens collection, subjects could opt-out of contribution
in part or completely.
Maternal venipuncture for blood collection is per-
formed at each study visit for consenting subjects. Add-
itionally, at the time of delivery, umbilical cord blood is
collected after delivery of the baby but prior to delivery
of the placenta. All plasma samples are aliquoted into
1 ml cryovials and stored at −80°C until assayed with
freeze/thaw cycles limited to a maximum of two. All
samples are analyzed in duplicate according to manufac-
turer instructions by a single investigator (NNZ) on the
same day to minimize day-to-day variation. Samples are
measured using a commercially available MagPix Milliplex®
kit (EMD Millipore) with a minimum of 100 positive beads
for each assay acquired with Luminex Magpix laser-based
fluorescent analytic test instrumentation (Luminex Corpor-
ation, Austin, TX). Manufacture supplied controls are used
to monitor coefficients of variation (<15% and 20% for
intra-assay and inter-assay, respectively). Samples are di-
luted as per manufacturer instructions. Serum evaluations
include adiponectin, c-reactive protein (CRP), interleukin-
1b, interleukin-6, interleukin-8, insulin, leptin, PAI-1 total,
and TNFα.
After delivery of the placenta, a 1x1cm segment of pla-
centa and a 1 cm length of umbilical cord are placed in
4% para-formaldehyde and a second similar sized speci-
men of each are placed in normal saline. Prior to study
completion, a single mouthwash sample of buccal epithe-
lial cells is collected with Scope brand mouthwash [54].
For the subset of subjects who have Cesarean delivery
for obstetric indications, and who consent, two 1x1 seg-
ments of omental (visceral adipose) and subcutaneous
adipose tissue are sampled after the uterus is returned to
the abdomen, and after the rectus fascia is re-approximated
but prior to skin closure, respectively. From each site, one
sample is placed in 4% para-formaldehyde and one in nor-
mal saline. The size and number of adiopocytes within the
samples is determined by light microscopy. Capillary dens-
ity is measured by counting number of cell profiles stained
with endothelial specific markers (e.g. vWF) in 10–20 fields
per biopsy specimen.
To quantify adipose deposition (visceral vs. subcutane-
ous) following maximal GWG [55], a subset of eligible
participants (whom either did not have a Cesarean deliv-
ery or whom had subcuticular stitches for skin closure
at the time of Cesarean, and whom have no metal for-
eign bodies), are asked to undergo optional magnetic res-
onance imaging (MRI) during the 2–4 day postpartum
inpatient stay. Images are captured centrally which de-
creases effect of postpartum fluid shifts that most often
settle peripherally in dependent regions.
Behavioral
At each of two study time points, dietary intake is
assessed using three telephone-administered 24-hour
(24HR) dietary recalls (two weekdays and one weekend
over a three-week window), with each call duration lasting
15–30 minutes. The first dietary assessment is conducted
in pregnancy at baseline, and then again at the three-
month postpartum assessment. 24HR dietary recalls are
considered the gold standard dietary assessment method
for population-based research, with three recalls per time
point being appropriate to examine inter- and intra- diet-
ary variation patterns [56]. These assessments are admin-
istered by trained dieticians who elicit information on
dietary intake utilizing the multiple-pass technique, allow-
ing for several distinct opportunities to obtain information
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about participants’ food intake during the previous
24 hours. This approach, and associated software, allow
for range and logic error checking, information
prompting and corrections. 24HR recalls are analyzed
using the University of Minnesota Nutrition Coordinat-
ing Center's (NCC) Nutrition Data System for Research
(NDS-R-2010) software (updated annually) [57]. The
system consists of data entry and analysis software and
comprehensive food nutrient databases. The database
contains over 18,000 foods (including culturally unique
foods) and 8,000 brand name products along with
values for 155 nutrients, nutrient ratios and other food
components, allowing for analysis of individual dietary
variations including portion size, preparation methods,
ingredients, assessments and timing of eating. A Diet-
ary Supplement Module captures supplements used by
participants.
Physical activity is assessed on the same phone call via
a validated 24HR physical activity recall [58,59]. Similar
to the dietary recalls, three physical activity recalls are
administered at baseline (in pregnancy) and then at
three months post-partum, each lasting 5–10 minutes.
Detailed information about specific types and intensities
of activities are summarized and metabolic equivalents
(METS) are calculated using Ainsworth and colleagues
compendium of physical activities [60].
Additionally, the Pregnancy and Physical Activity
Questionnaire (PPAQ) [61], modified for administration
in the post-partum period, is administered by research
personnel at all assessment time points. The PPAQ is a
self-administered measure of physical activity that has
been validated using ActiGraph accelerometers. This
measure provides physical activity data in various domains
relevant to pregnant and postpartum women, including
occupational activity, household/care-giving activities, and
sports/exercise [61].
Extent of breastfeeding, breast pumping, formula and
other infant feeding practices are assessed with select
questions from the Center for Disease Control’s (CDC)
maternal-infant feeding study [62] and a modified ver-
sion of the United Kingdom’s Medical Research Council
Epidemiology Unit’s feeding and growth questionnaire
[63]. Questions probe for exclusivity of breastfeeding
versus extent to which other liquid and food products
are offered to infants so as to quantify maternal energy
expenditure with regards to lactation efforts.
Sleep quantity and quality are assessed with the 19
item Pittsburgh Sleep Quality Index [64], which has
been used to assess sleep disturbance in pregnant [65]
and post-partum [66] women.
Tobacco and alcohol use are queried at each study visit
and recorded. Selected items from the Behavioral Risk
Factor Surveillance System questionnaire [67] are uti-
lized to assess tobacco.
Cognitive/Psychological
Self-administered survey tools are used to assess psycho-
logical and cognitive/attitudinal variables at all study time
points. Areas assessed include anxiety evaluated by the
20-item Spielberger State Anxiety Inventory(SSAI)) [68],
depression as measured by the the 10-item Edinburgh
Postnatal Depression Scale (EPDS) [69,70], stress as
assessed by the 10-item Perceived Stress Scale [71], a
measure of life events [72], and quality of life assessed via
the SF-12 [73]. We also assessed positive affect using the
Happiness Scale modified (4 questions) [74]. Attitude to-
wards pregnancy and weight gain were assessed using the
modified Pregnancy and Weight Gain Attitude Scale (18
questions) [75] and questions on pregnancy intendedness.
Selected eating behaviors namely emotional eating, uncon-
trolled eating and cognitive restraint are evaluated via the
18-item Three-Factor Eating Questionnaire [76], and a 28-
item inventory assesses food cravings [77].
Sociocultural
Sociocultural survey assessments are completed at each
study time point and predominantly evaluate overall so-
cial support using the 20-item Medical Outcomes Study
(MOS) social support survey [78] and pregnancy-specific
social supports [79-81] (Lobel: The prenatal social sup-
port instrument (PSSI), unpublished).
Weight outcomes
Total gestational weight gain (GWG) is calculated by
subtracting self-reported pre-pregnancy weight from
weight at time of delivery admission or documented
weight at last prenatal visit. GWG is considered continu-
ously and categorically (inadequate, appropriate or ex-
cessive, as per IOM-recommended ranges) over the
course of gestation and at delivery. Categorical GWG as-
sessment is BMI-specific and accounts for gestational
age at measurement as per IOM recommendations [82].
Minimum and maximum gain at each gestational age
week is calculated based on recommended velocities of
gain in first trimester (ending week 13) and throughout
second and third trimester assuming the following gain
ranges achieved by 40th week: 28–40 lbs for women of
underweight prepregnancy BMI, 25–35 lbs for normal,
15–25 lbs for overweight, and 11–20 lbs for obese
gravidas [3].
Postpartum weight loss or retention is calculated at
6 weeks, 3 months and 6 months postpartum by sub-
tracting measured weights at these study visits from
measured weight at last prenatal care visit. All study spe-
cific weights are measured three times on a digital scale
(TANITA BWB-800AS) and averaged.
Infant weights are measured in order to assess associa-
tions between maternal variables and infant weight. In-
fant weights are measured at all postpartum assessment
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time points when the infant is in attendance with mater-
nal subjects, utilizing a Tanita BD-590 pediatric scale.
Additionally, pediatrician records are obtained once each
child reaches a year of life to capture length, weight and
head circumference measurements for the offspring of
each maternal participant from birth through one year.
Participant safety
To ensure the safety of participants who might be ex-
periencing mood disorders, the EPDS is scored immedi-
ately after completion and before the participant leaves
the study office. Participants scoring 12 or greater (sug-
gestive of possible clinical depression) who score nega-
tive on the suicide question are encouraged to contact
their provider to discuss symptoms. Participants scoring
12 or greater and with positive responses to the suicide
question are considered at acute risk of injury or harm;
an appropriately trained person performs a safety assess-
ment and refers for immediate psychiatric evaluation
if warranted.
Statistical analysis, power and sample size
The primary outcomes for this study are change in
weight from pre-pregnancy to last measured prenatal
weight prior to delivery (i.e. gestational weight gain or
change) and change in weight from last measured pre-
natal weight to weight at 6 months post-partum (i.e.
postpartum weight change). Additional weight measures
are taken at each prenatal visit and at 6 weeks and
3 months postpartum. One of the main purposes of this
study is to collect data related to these outcome as there
is limited data in the literature thus we used standard
deviation units as a way to determine a reasonable sam-
ple size. Assuming the definition of the primary out-
comes from above and using a paired t-test for the main
analysis with a two-tailed alpha = 0.05 and power = 0.80,
we are able to detect a difference of as little as 0.30
standard deviation units with 100 patients. Adjusting for
potential drop-out or missed data of 10%, we planned
recruitment of 110 patients for either change in weight
outcomes. To estimate detectable associations between
predictors and either change in weight outcomes, we will
use correlations since regression coefficients are essen-
tially standardized correlations. So, for correlations be-
tween predictors and outcomes, we will have power =
0.80 to detect correlations of 0.28 with 100 patients in a
regression model (as described below). In fact, because
we will use multivariate regression models to partition
the overall variance, we expect to have more power
than estimated.
Descriptive statistics will be calculated in the usual
way. To estimate the gestational weight change and the
post-partum weight change, we will first calculate the
change in weight as indicated above and use a standard
paired t-test (if the weight change is normally distrib-
uted) or a Wilcoxon non-parametric test (if weight
change is not normally distributed) to determine if there
is a significant change in weight from pre-pregnancy to
last prenatal visit preceding delivery weight and from
this to six months postpartum. To determine the effect
of the various predictors on these outcomes, we will use
two approaches to model construction. First, we will use
general linear models to model change in weight during
gestation or change in weight post-partum, using the
definitions for these outcomes from above. Second, we
will use a mixed effects model to examine the individual
trajectories of change over time, using all of the mea-
sures of weight throughout the gestation and post-
partum periods. The predictors will be similar for the
two analytic approaches, based on the conceptual model
in Figure 1. In general we will first investigate the effect
of related groups of predictors (such as the behavioral
predictors from Table 1) and then combine the resulting
significant factors into the final model. With a relatively
limited sample size, this will be a feasible approach –
and potentially more revealing – than a more omnibus
variable selection process.
Results
Demographic characteristics of the study sample (n =
110) are presented in Table 2. As anticipated, the study
population is relatively healthy and consistent with the
general population seeking prenatal care in the faculty
and resident ambulatory obstetric clinics that constitute
the study sites. The mean age is 28.3 years, with a mean
pre-pregnancy BMI of 25.7 kg/m indicating that a ma-
jority of the women were overweight or obese prior to
becoming pregnant. The mean gestational age at recruit-
ment was 32.5 weeks. One-third of the cohort is non-
white, over a quarter are Latina/Hispanic, 15.5% report a
primary language at home other than English, and al-
most a quarter are foreign born. The majority of partici-
pants are multigravida, are high school graduates or
have higher levels of education, and work outside of the
home. Almost half of the sample reported household
financial challenges.
Discussion
Maternal and childhood obesity are significant public
health issues that affect general immediate and long
term health of women and children. Women receive
more medical attention in pregnancy and the postpar-
tum period than at any other healthful time in their
lives; this time is ripe for intervention, especially as
women are generally motivated to improve their health
for benefit of their offspring. However, this is also a time
of significant adaptations as it relates to physical, physio-
logical, hormonal and behavioral changes (including
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Table 2 Cohort demographic characteristics
Demographic characteristics Mean SD Median Interquartile range
Age (years) 28.3 5.1 28 24-32
Gestational age @baseline study visit (weeks) 32.5 1.8 32.6 31.4-33.7
N %*
Prepregnancy BMI (kg/m2) (n = 110)
Underweight 1 0.9
Normal 52 47.3
Overweight 32 29.1
Obese 25 22.7
Race (n = 93)
White 63 67.7
Black/African American 7 7.5
Asian 5 5.4
Hawaiian/Pacific Islander 1 1.1
Other 11 11.8
Multiracial 6 6.5
Ethnicity (n = 99)
Not Hispanic, Latino or Spanish 71 71.7
Hispanic, Latino or Spanish origin 28 28.3
Non-U.S. born (n = 99) 24 24.2
Non-English primary home language (n = 98) 16 15.5
Multigravida (n = 108) 75 69.4
Relationship
In relationship with father of baby (n = 98) 92 93.9
Married (n = 99) 60 60.6
Education (n = 99)
≤8th grade 2 2.0
>8th grade, < high school 3 3.0
High school graduate or GED 20 20.2
Trade or technical school after HS 5 5.1
Some college 25 25.3
4 year college degree 23 23.2
Other 21 21.2
Employment (n = 100)
Working full or part-time outside home 65 65.5
Homemaker 15 15.0
Household ability to make ends meet (n = 100)
Great difficulty 12 12.0
Some difficulty 36 36.0
No difficulty 52 52.0
Location of care (n = 109)
Resident practice 34 31.2
Faculty practice 75 68.9
*Percentiles based on total number for whom data available and does not account for missingness.
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sleep, diet, physical activity, smoking habits), new and
different stressors, mood fluctuations, and changes in
sociocultural identity and responses from the social en-
vironment, along with numerous other weight relevant
factors. Excessive pregnancy weight gain and lack of
postpartum weight loss [9,83] are associated with ma-
ternal obesity which increases the risk of diabetes, car-
diac disease [83], some cancers [16], and other health
consequences. Maternal obesity and excessive preg-
nancy weight gain are associated with childhood obesity
[3] and its downstream effects which are varied and in-
clude metabolic dysfunction, asthma, and behavioral
disorders [84]. The critical interplay of socioeconomic
issues and weight-related behavioral and other patterns
[84] are infrequently or inadequately addressed in
weight interventions to improve maternal and offspring
health. Comprehensive examination and understanding
of behavioral, social, cultural and environmental con-
texts through a lifespan biopsychosocial model is crit-
ical to the design of future interventions with the
potential to substantially and effectively improve mater-
nal and child health.
This study is grounded in theory as conceptualized by
women’s weight trajectories during both pregnancy and
the post-partum period, and long-term maternal and
child health and well-being, within a lifespan biopsycho-
social framework. This study was designed to determine
the feasibility of understanding multifactorial influences
on maternal pregnancy and postpartum weight trajector-
ies with the goal of gaining critical foundations of know-
ledge, experience and infrastructure on which to base
future intervention research. Large trials recruiting so-
cioeconomically and racially/ethnically diverse women
are necessary to identify and analyze moderators and
mediators of weight gain and loss as they relate to preg-
nancy and the postpartum period, and elucidate their ef-
fects on maternal and offspring health. We piloted
critical variables that are relevant to future large scale
studies addressing these issues.
The strengths of this study protocol are several. This
is a longitudinal study design that includes a large num-
ber of variables and comprehensive assessments. Each of
these critical factors individually and/or in aggregate ex-
amines different contexts of the biopsychosocial model.
We were able to recruit a diverse population of women
with 28% of our subjects being Latina, almost a quarter
being non-US born and with approximately 15% from
households speaking primary languages other than
English. The study was able to recruit a socioeconomi-
cally diverse sample, as evidenced by their range of abil-
ities to meet their household needs. This is critical for
analysis of interactions amongst the biologic, psycho-
logic, and social variables. The subject population repre-
sents women of childbearing age with more than half
being overweight or obese in pregnancy [85], including
one out of 5 being obese [86].
A significant strength is the pilot nature of this study –
performing a pilot acknowledges the importance of deter-
mining the feasibility of and acceptance of the design and
overall burden to targeted participants. This is critical be-
fore embarking on a larger scale endeavor. However, our
relatively modest sample size is a limitation. Adequately
powering an intervention study with consideration of me-
diators and modifiers will require a larger sample size and
is beyond the scope of this project. Generalizability of
study findings may be limited by exclusion of non-English
speakers, women with pre-existing physical and mental
health conditions, adolescents, and women who did not
seek care in early pregnancy.
Evidence of feasibility, acceptability, and consideration
of weight influencing factors and behaviors other than diet
and physical activity are essential to future epidemiological
and intervention studies, including the design of new in-
terventions that optimize appropriate maternal gestational
weight gain and subsequent postpartum weight loss. We
anticipate that the current study will produce valuable
data and insights to help guide application of these find-
ings to interventions targeting maternal health for mater-
nal benefit but also for offspring benefit, thus promoting
intergenerational health.
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